Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesions

Tiffany J. Braley, Young Hen Lee, Suyash Mohan, Benjamin M. Segal, Sarah Berini, Ashok Srinivasan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

OBJECTIVE: To analyze differences in corpus callosum diffusion tensor imaging metrics among patients with relapsing-remitting multiple sclerosis (MS) (RRMS) and secondary progressive MS (SPMS) with enhancing and nonenhancing cerebral lesions. METHODS: One-way analysis of variance and multiple linear regression models were used to assess the relationship between MS subtype, the presence of enhancing lesions, and fractional anisotropy (FA)/mean diffusivity (MD) values of the genu, body, and splenium of the corpus callosum from 22 patients with RRMS and 25 patients with SPMS. RESULTS: Analyses of variance: The subjects with SPMS with enhancing lesions had significantly lower genu and body FA values than those with nonenhancing SPMS and significantly lower genu, body, and splenium FA values than those with RRMS. Regression models: Enhancement was associated with decreased genu FA (P = 0.014). Secondary progressive MS was associated with decreased genu (P = 0.002) and splenium FA (P < 0.001) and significantly increased MD values. CONCLUSION: Patients with SPMS with enhancing lesions may be at increased risk for neuronal damage compared to nonenhancing SPMS and RRMS subtypes.

Original languageEnglish
Pages (from-to)410-415
Number of pages6
JournalJournal of Computer Assisted Tomography
Volume36
Issue number4
DOIs
Publication statusPublished - 2012 Jul 1

Fingerprint

Diffusion Tensor Imaging
Corpus Callosum
Anisotropy
Gadolinium
Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Linear Models
Analysis of Variance
Relapsing-Remitting Multiple Sclerosis

Keywords

  • diffusion tensor imaging
  • inflammation
  • MRI
  • multiple sclerosis
  • neuroimmunology

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesions. / Braley, Tiffany J.; Lee, Young Hen; Mohan, Suyash; Segal, Benjamin M.; Berini, Sarah; Srinivasan, Ashok.

In: Journal of Computer Assisted Tomography, Vol. 36, No. 4, 01.07.2012, p. 410-415.

Research output: Contribution to journalArticle

@article{a98468b5a07845b4a034f78ec4e2f1c5,
title = "Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesions",
abstract = "OBJECTIVE: To analyze differences in corpus callosum diffusion tensor imaging metrics among patients with relapsing-remitting multiple sclerosis (MS) (RRMS) and secondary progressive MS (SPMS) with enhancing and nonenhancing cerebral lesions. METHODS: One-way analysis of variance and multiple linear regression models were used to assess the relationship between MS subtype, the presence of enhancing lesions, and fractional anisotropy (FA)/mean diffusivity (MD) values of the genu, body, and splenium of the corpus callosum from 22 patients with RRMS and 25 patients with SPMS. RESULTS: Analyses of variance: The subjects with SPMS with enhancing lesions had significantly lower genu and body FA values than those with nonenhancing SPMS and significantly lower genu, body, and splenium FA values than those with RRMS. Regression models: Enhancement was associated with decreased genu FA (P = 0.014). Secondary progressive MS was associated with decreased genu (P = 0.002) and splenium FA (P < 0.001) and significantly increased MD values. CONCLUSION: Patients with SPMS with enhancing lesions may be at increased risk for neuronal damage compared to nonenhancing SPMS and RRMS subtypes.",
keywords = "diffusion tensor imaging, inflammation, MRI, multiple sclerosis, neuroimmunology",
author = "Braley, {Tiffany J.} and Lee, {Young Hen} and Suyash Mohan and Segal, {Benjamin M.} and Sarah Berini and Ashok Srinivasan",
year = "2012",
month = "7",
day = "1",
doi = "10.1097/RCT.0b013e31825c6cee",
language = "English",
volume = "36",
pages = "410--415",
journal = "Journal of Computer Assisted Tomography",
issn = "0363-8715",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesions

AU - Braley, Tiffany J.

AU - Lee, Young Hen

AU - Mohan, Suyash

AU - Segal, Benjamin M.

AU - Berini, Sarah

AU - Srinivasan, Ashok

PY - 2012/7/1

Y1 - 2012/7/1

N2 - OBJECTIVE: To analyze differences in corpus callosum diffusion tensor imaging metrics among patients with relapsing-remitting multiple sclerosis (MS) (RRMS) and secondary progressive MS (SPMS) with enhancing and nonenhancing cerebral lesions. METHODS: One-way analysis of variance and multiple linear regression models were used to assess the relationship between MS subtype, the presence of enhancing lesions, and fractional anisotropy (FA)/mean diffusivity (MD) values of the genu, body, and splenium of the corpus callosum from 22 patients with RRMS and 25 patients with SPMS. RESULTS: Analyses of variance: The subjects with SPMS with enhancing lesions had significantly lower genu and body FA values than those with nonenhancing SPMS and significantly lower genu, body, and splenium FA values than those with RRMS. Regression models: Enhancement was associated with decreased genu FA (P = 0.014). Secondary progressive MS was associated with decreased genu (P = 0.002) and splenium FA (P < 0.001) and significantly increased MD values. CONCLUSION: Patients with SPMS with enhancing lesions may be at increased risk for neuronal damage compared to nonenhancing SPMS and RRMS subtypes.

AB - OBJECTIVE: To analyze differences in corpus callosum diffusion tensor imaging metrics among patients with relapsing-remitting multiple sclerosis (MS) (RRMS) and secondary progressive MS (SPMS) with enhancing and nonenhancing cerebral lesions. METHODS: One-way analysis of variance and multiple linear regression models were used to assess the relationship between MS subtype, the presence of enhancing lesions, and fractional anisotropy (FA)/mean diffusivity (MD) values of the genu, body, and splenium of the corpus callosum from 22 patients with RRMS and 25 patients with SPMS. RESULTS: Analyses of variance: The subjects with SPMS with enhancing lesions had significantly lower genu and body FA values than those with nonenhancing SPMS and significantly lower genu, body, and splenium FA values than those with RRMS. Regression models: Enhancement was associated with decreased genu FA (P = 0.014). Secondary progressive MS was associated with decreased genu (P = 0.002) and splenium FA (P < 0.001) and significantly increased MD values. CONCLUSION: Patients with SPMS with enhancing lesions may be at increased risk for neuronal damage compared to nonenhancing SPMS and RRMS subtypes.

KW - diffusion tensor imaging

KW - inflammation

KW - MRI

KW - multiple sclerosis

KW - neuroimmunology

UR - http://www.scopus.com/inward/record.url?scp=84863944784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863944784&partnerID=8YFLogxK

U2 - 10.1097/RCT.0b013e31825c6cee

DO - 10.1097/RCT.0b013e31825c6cee

M3 - Article

VL - 36

SP - 410

EP - 415

JO - Journal of Computer Assisted Tomography

JF - Journal of Computer Assisted Tomography

SN - 0363-8715

IS - 4

ER -